Enavate Sciences GP, LLC

CIK 1953107 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Enavate Sciences GP, LLC.

Recent SEC filings

FiledFormAccession number
Aug 31, 2026N-PX0001104659-26-103905
Aug 19, 2026SCHEDULE 13D/A0001953107-26-000015
Aug 14, 202613F-HR0001953107-26-000012
May 15, 202613F-HR0001953107-26-000008
Mar 11, 2026SCHEDULE 13D/A0001953107-26-000005
Feb 17, 202613F-HR0001953107-26-000003
Dec 23, 2025SCHEDULE 13D/A0001953107-25-000021
Dec 22, 2025SCHEDULE 13D/A0001953107-25-000019
Nov 14, 202513F-HR0001953107-25-000014
Oct 14, 2025SCHEDULE 13D/A0001953107-25-000010
Sep 15, 2025SCHEDULE 13D/A0001953107-25-000007
Aug 14, 202513F-HR0001415889-25-021852
May 15, 202513F-HR0001415889-25-013132
Feb 18, 2025SCHEDULE 13D0001415889-25-004410
Feb 14, 202513F-HR0001104659-25-014094
Oct 22, 2024SC 13D0001104659-24-110566
Oct 17, 202440001415889-24-025354
Oct 10, 202430001415889-24-025000
Sep 23, 2024SC 13D0001104659-24-102046
Sep 18, 202440001415889-24-023609
Sep 12, 202430001415889-24-023342